Platelet-activating factor stimulates secretion of respiratory glycoconjugate from human airways in culture.

The Journal of Allergy and Clinical Immunology
S K GoswamiZ Marom

Abstract

Platelet-activating factor (PAF) is a naturally occurring phospholipid that acts as a potent mediator of inflammation and bronchoconstriction. Since mucus secretion accompanies many pulmonary-allergic reactions, we examined the effect of PAF on respiratory glycoconjugate (RGC) release from human airways in vitro. PAF, in concentrations of 5 to 100 ng/ml, induced a specific, dose-dependent release of [3H]RGC from human airways in vitro (range of 15% to 120% increase above control, p less than 0.001; n = 8). Time-course studies revealed that RGC release reached its peak level by 60 minutes, and by the end of 4 hours, decreased almost to the baseline level, suggesting a stimulatory effect on secretion rather than synthesis. PAF analog, RO 19-3704, which is a PAF-receptor antagonist, inhibited RGC secretion mediated by PAF in a dose-dependent manner with an inhibitory concentration of 50% of 70 ng/ml. BW 755C and nordihydroguaiaretic acid, but not indomethacin, inhibited RGC release by PAF. LY 171883, a specific leukotriene D4-receptor antagonist, totally inhibited the release of RGC by PAF. Similar results were observed with FPL 55712. PAF-treated airways generated peptidoleukotrienes significantly above control airways in associa...Continue Reading

References

Jun 28, 1979·Nature·M ChignardJ Benveniste
Apr 25, 1985·Biochimica Et Biophysica Acta·S K Goswami, R M Gould
Apr 1, 1970·Lipids·D C Zimmerman, B A Vick
Jan 1, 1984·Experimental Lung Research·J H ShelhamerM Kaliner
Jul 1, 1983·The Journal of Clinical Investigation·Z MaromM Kaliner
May 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·F HirataJ Axelrod
Dec 1, 1980·The Journal of Clinical Investigation·J H ShelhamerM Kaliner

❮ Previous
Next ❯

Citations

May 1, 1996·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·L KahhakJ Benveniste
Jan 1, 1991·Annals of the New York Academy of Sciences·P J Barnes
Feb 1, 1992·American Journal of Respiratory Cell and Molecular Biology·R D RievesJ H Shelhamer
Feb 22, 2008·Journal of Occupational Medicine and Toxicology·Rene SchmidtUlrich Wagner
May 9, 2008·Pulmonary Pharmacology & Therapeutics·Brendan J Canning, Yangling Chou
Jun 1, 1992·Pulmonary Pharmacology·J D Lundgren, J N Baraniuk
Jun 1, 1991·The Journal of Allergy and Clinical Immunology·J TamaokiT Takizawa
Sep 4, 2015·Physiological Reviews·Jonathan H Widdicombe, Jeffrey J Wine
Feb 13, 2001·American Journal of Physiology. Lung Cellular and Molecular Physiology·M KomoriN Hara
Jan 1, 1991·Pulmonary Pharmacology·J N Baraniuk

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.